Legend Biotech (LEGN) Other Gross PP&E Adjustments: 2019-2025
Historic Other Gross PP&E Adjustments for Legend Biotech (LEGN) over the last 5 years, with Sep 2025 value amounting to -$142.3 million.
- Legend Biotech's Other Gross PP&E Adjustments fell 43.12% to -$142.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$478.7 million, marking a year-over-year decrease of 27.71%. This contributed to the annual value of -$101.9 million for FY2024, which is 26.62% down from last year.
- Per Legend Biotech's latest filing, its Other Gross PP&E Adjustments stood at -$142.3 million for Q3 2025, which was down 11.89% from -$127.2 million recorded in Q2 2025.
- Legend Biotech's Other Gross PP&E Adjustments' 5-year high stood at -$7,547 during Q1 2021, with a 5-year trough of -$142.3 million in Q3 2025.
- Its 3-year average for Other Gross PP&E Adjustments is -$98.8 million, with a median of -$99.5 million in 2024.
- As far as peak fluctuations go, Legend Biotech's Other Gross PP&E Adjustments rose by 8.08% in 2021, and later plummeted by 526,877.61% in 2022.
- Quarterly analysis of 5 years shows Legend Biotech's Other Gross PP&E Adjustments stood at -$38.3 million in 2021, then plummeted by 45.21% to -$55.6 million in 2022, then tumbled by 44.81% to -$80.5 million in 2023, then dropped by 26.62% to -$101.9 million in 2024, then plummeted by 43.12% to -$142.3 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$142.3 million for Q3 2025, versus -$127.2 million for Q2 2025 and -$107.2 million for Q1 2025.